Martino E, Aghini-Lombardi F, Mariotti S, Lenziardi M, Baschieri L, Braverman L E, Pinchera A
J Endocrinol Invest. 1986 Jun;9(3):201-7. doi: 10.1007/BF03348098.
Amiodarone iodine induced thyrotoxicosis occurs frequently in patients residing in areas of mild iodine deficiency and in patients with preexisting goiter. Drug therapy of the hyperthyroidism is often unsuccessful. Twenty-three patients with amiodarone induced thyrotoxicosis were either not treated, treated with 40 mg methimazole daily or with methimazole and 1 gm potassium perchlorate daily for up to 40 days and then with methimazole alone. Thyrotoxicosis was more likely to spontaneously remit in patients without goiter. Therapy with methimazole alone was unsuccessful in inducing euthyroidism in 5 patients with goiter. However, combined therapy with methimazole and potassium perchlorate rapidly alleviated hyperthyroidism in almost all patients with goiter. This drug combination is successful because perchlorate inhibits the active transport of iodine into the thyroid and methimazole blocks the intrathyroidal synthesis of thyroid hormones.
胺碘酮碘所致甲状腺毒症在轻度碘缺乏地区的居民以及原有甲状腺肿的患者中频繁发生。甲状腺功能亢进的药物治疗往往不成功。23例胺碘酮所致甲状腺毒症患者要么未接受治疗,要么每日服用40毫克甲巯咪唑,要么每日服用甲巯咪唑和1克高氯酸钾,持续40天,之后仅服用甲巯咪唑。无甲状腺肿的患者甲状腺毒症更有可能自发缓解。单独使用甲巯咪唑治疗未能使5例有甲状腺肿的患者恢复甲状腺功能正常。然而,甲巯咪唑和高氯酸钾联合治疗几乎使所有有甲状腺肿的患者的甲状腺功能亢进迅速得到缓解。这种药物组合之所以成功,是因为高氯酸盐抑制碘向甲状腺的主动转运,而甲巯咪唑阻断甲状腺内甲状腺激素的合成。